NewsNewsDetails
Cardinal Health and CVS Health sign a binding letter of intent to extend the pharmaceutical distribution agreement
PR Newswire
1h ago
Ai Focus
Cardinal Health announced that it has signed a binding letter of intent with CVS Health to extend the existing distribution agreement until June 30, 2032, and to continue the current scope of distribution services. The company also reiterated its earnings guidance for the fiscal year 2027, which is not related to GAAP, to grow by 13% to 15%, or from $12.40 to $12.60 per share.
Helpful
No.Help

Dublin, Ohio, October 1st / PRNewswire / -- Cardinal Health (New York Stock Exchange ticker: CAH) announced today that it has signed a binding letter of intent to extend its existing distribution agreement with CVS Health until June 30, 2032, and to continue the current scope of distribution services provided by Cardinal Health.

Cardinal Health CEO Jason Hollar stated: "We value our long-standing partnership with CVS Health and look forward to continuing to combine our best capabilities to serve their customers."

Regarding this renewal, Cardinal Health reiterates its guidance for non-GAAP earnings per share for the fiscal year 2027 to grow by 13% to 15%, which is $12.40 to $12.60 per share. At the same time, it reiterates its long-term guidance for non-GAAP earnings per share growth rate to be 12% to 14%. The company stated that more updates may be announced at the next quarterly earnings conference call on November 5, 2026.

About Cardinal Health

Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a provider of home health products and services directly to patients; an operator of nuclear pharmacies and manufacturing facilities; as well as a provider of performance and data solutions. The company is driven by a customer-centric philosophy that promotes continuous improvement and brings innovative solutions to help enhance people's daily lives. For more information, please visit cardinalhealth.com and its news center.

Contact Information

Media: Erich Timmerman, [ email protected ], 614.757.8231

Investor: David Frost, [email protected], 614.757.7852

The growth rate guidance for the fiscal year 2027 is based on the adjusted performance of fiscal year 2026, which does not include the benefits derived from the IEEPA tariff refunds in fiscal year 2026.

Tip
$0
Like
0
Save
0
Views 17
HKWDB reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”，and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
What has become of Trump's plans to distribute money to Americans during his second term?
This article outlines various "money distribution" schemes proposed or promoted during Trump's second term, including DOGE dividends, tariff rebate checks, air traffic control staff bonuses, Trump Accounts, military "Warrior Dividend", direct healthcare subsidies, and ACA refund checks, and explains the progress and obstacles associated with each of them.
Businessinsider
·2026-10-01 20:18:10
5
SpyGlass Pharma Acquires Advanced Vision Science to Lock in Scalable Commercialized IOL Supply and Accelerate Expansion of Lens Product Portfolio
SpyGlass Pharma Announces the Acquisition of All Outstanding Common Shares of Advanced Vision Science, a Subsidiary of Santen Pharmaceutical, for Approximately $13 Million in Cash. The company stated that this move will lock in scalable commercialized intraocular lens production capacity for BIM - IOL System during its III phase of registration trials and accelerate the expansion of its high-end lens product portfolio.
GlobeNewswire
·2026-10-01 20:08:46
10
Powerus has completed the merger with Aureus Greenway Holdings and will continue to trade on NASDAQ under the name of PUSA.
Powerus and Aureus Greenway Holdings completed the merger announced earlier on October 1, 2026. Following the merger, AGH was renamed to Powerus Corporation. The company's shares continued to trade on the NASDAQ capital market under the code PUSA, which remained unchanged despite the completion of the merger.
GlobeNewswire
·2026-10-01 20:08:43
10
Illinois agrees to push back crypto tax by six months, with industry litigation battles continuing
Both parties agree to defer 0.2% of the tax until July 1st, provided that the court approves the agreement, which will allow the state government and the industry to focus on the legal dispute.
CoinDesk
·2026-10-01 20:08:41
17
Corteva Announces Private Exchange Offers for EIDP Preferred Stocks in 2030, 2032, and 2033, Agrees to Collect Maturities, and Publishes Final Results
According to Corteva, its wholly-owned subsidiary Vylor has received the final results of the private exchange offers and related consent solicitations for the three prior preferred notes of EIDP. The relevant transactions are expected to be completed in tandem with the split plan of Corteva, with a timeline anticipated to be around October 1, 2026.
PR Newswire
·2026-10-01 19:46:38
16
View More
Latest from Author
Refresh
arrow
iQSTEL claims that Edison has initiated an overwriting process, assigning a valuation of $6 per share
iQSTEL claims that Edison has initiated an overwriting process, assigning a valuation of $6 per share
16m ago   9peopleViews
10 Federal Acquires Fort Worth Shopping Center, Second Retail Asset Acquisition of the Month
10 Federal Acquires Fort Worth Shopping Center, Second Retail Asset Acquisition of the Month
16m ago   12peopleViews
Corteva Announces Private Exchange Offers for EIDP Preferred Stocks in 2030, 2032, and 2033, Agrees to Collect Maturities, and Publishes Final Results
Corteva Announces Private Exchange Offers for EIDP Preferred Stocks in 2030, 2032, and 2033, Agrees to Collect Maturities, and Publishes Final Results
38m ago   16peopleViews
Recommended